<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00721825</url>
  </required_header>
  <id_info>
    <org_study_id>Moleac</org_study_id>
    <nct_id>NCT00721825</nct_id>
  </id_info>
  <brief_title>Study of NeuroAid In Enhancing Recovery After Stroke</brief_title>
  <acronym>TIERS</acronym>
  <official_title>A Double-Blinded, Placebo-Controlled, Randomized Phase II Pilot Study to Investigate the Potential Efficacy of a Traditional Chinese Medicine NeuroAid In Enhancing Recovery After Stroke (TIERS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moleac Pte Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moleac Pte Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      TIERS is a phase II to generate detailed preliminary data on the efficacy of NeuroAid in
      post-stroke recovery, and to assess the utility of the rehabilitation outcome measure
      instruments used.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl-Meyer assessment</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Independence Measure (FIM) scale</measure>
    <time_frame>4 weeks and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fugl-Meyer subscores</measure>
    <time_frame>4 weeks and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIHSS and NIHSS subscores</measure>
    <time_frame>4 weeks and 8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Stroke</condition>
  <condition>Cerebral Infarction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Neuroaid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Neuroaid matched placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neuroaid</intervention_name>
    <description>Neuroaid capsules, 4 capsules, three times per day, during one month</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neuroaid matched Placebo</intervention_name>
    <description>Neuroaid matched placebo 4 capsules three times per day during one month</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject had cerebral infarction confirmed by Computed Tomography (CT scan or Magnetic
             Resonance Imaging (MRI) imaging

          -  Presents within 1 month after stroke onset

          -  Presents with motor power of from grade 1 - 4/5 in at least one limb

          -  Has a pre-stroke modified Rankin score ≤ 1.

          -  Age between 21 and 80 years old

          -  Female subjects are eligible to participate in the trial if they are of non
             childbearing potential (hysterectomy or post-menopausal)

          -  Subject or legally acceptable representative is willing and able to provide written
             informed consent

          -  Subject and carer are willing and able to comply with investigational drug
             administration schedule.

        Exclusion Criteria:

          -  Subject has received thrombolysis

          -  Subject has evidence of intra-cerebral hemorrhage on brain CT scan or MRI

          -  Subject has definite indication for full-dose or long-term anticoagulation therapy

          -  Subject has other significant non-ischemic brain lesion which could affect function
             disability

          -  Subject has co-existing systemic diseases: terminal cancer, renal failure (creatinine
             &gt;200 μmol/L, if known), cirrhosis, severe dementia or psychosis

          -  Subject has a history of previous stroke/s

          -  Subject has participated in another clinical trial within the last three months

          -  Subject has aphasia or any other cognitive disabilities which prevent cooperation with
             study instructions

          -  Subject has dense hemiplegia (grade 0 motor power)

          -  Subject has haemoglobin level of &lt;10mg/dl on admission

          -  Subject has a history of craniotomy or seizures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keng He Kong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tan Tock Seng Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tan Tock Seng Rehabilitation department</name>
      <address>
        <city>Singapore</city>
        <zip>569766</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2008</study_first_submitted>
  <study_first_submitted_qc>July 23, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2008</study_first_posted>
  <last_update_submitted>July 23, 2008</last_update_submitted>
  <last_update_submitted_qc>July 23, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr Kong Keng He - senior consultant</name_title>
    <organization>Tan Tock Seng Hospital</organization>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Cerebral infarct</keyword>
  <keyword>Rehabilitation</keyword>
  <keyword>Double blind Randomized</keyword>
  <keyword>Placebo controlled</keyword>
  <keyword>Traditional Chinese Medicine</keyword>
  <keyword>Neuroaid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

